Pseudoephedrine and Vertigo
Pseudoephedrine can cause dizziness as a recognized adverse effect, but vertigo is not specifically listed as a common side effect in FDA labeling or major clinical guidelines. The FDA drug label explicitly warns that "nervousness, dizziness, or sleeplessness" may occur with pseudoephedrine use 1.
Understanding the Distinction
The term "dizziness" encompasses a broad spectrum of sensations, while vertigo specifically refers to a false sensation of rotational movement. The evidence distinguishes between these:
- Dizziness is a documented side effect of pseudoephedrine according to FDA labeling, appearing in the "stop use and ask a doctor if" section 1
- True vertigo (rotational sensation from vestibular dysfunction) is not specifically mentioned in comprehensive rhinitis management guidelines that extensively discuss pseudoephedrine's side effect profile 2
Documented Side Effects of Pseudoephedrine
The established adverse effects from oral α-adrenergic agents like pseudoephedrine include 2:
- Cardiovascular effects: Elevated blood pressure (mean increase 0.99 mmHg systolic), increased heart rate (2.83 beats/min), palpitations
- Central nervous system effects: Insomnia, irritability, nervousness, tremor, sleep disturbance
- Other effects: Loss of appetite, dizziness
Clinical Context
When evaluating dizziness in patients taking pseudoephedrine:
- Consider the mechanism: Pseudoephedrine causes vasoconstriction through α-adrenergic receptor activation, which can affect blood pressure and potentially cause lightheadedness or presyncope rather than true vestibular vertigo 2
- Timing matters: If dizziness occurs after starting pseudoephedrine, discontinuation should be considered 1
- Alternative causes: In patients presenting with true vertigo (rotational sensation), other etiologies should be investigated rather than attributing symptoms solely to pseudoephedrine 3
Cautions and Contraindications
Pseudoephedrine should be used with particular caution in patients with 2:
- Cerebrovascular disease (where dizziness/vertigo symptoms would be especially concerning)
- Cardiovascular disease, arrhythmias, or angina
- Hypertension (though blood pressure elevation is rarely noted in normotensive patients)
- Hyperthyroidism
- Closed-angle glaucoma
- Bladder neck obstruction
In older adults and young children, oral decongestants should be used with heightened caution as these populations may be more susceptible to adverse effects including dizziness 2.
Practical Recommendation
If a patient develops dizziness while taking pseudoephedrine, discontinue the medication and reassess symptoms 1. If true rotational vertigo persists after discontinuation, pursue standard vestibular evaluation as the pseudoephedrine is unlikely to be the primary cause. Consider alternative decongestant strategies such as short-term topical oxymetazoline (≤3-5 days) or intranasal corticosteroids, which have more favorable side effect profiles 2, 4.